Trinity Biotech | Omløpsmidler



Current Assets Endring Dato
Abbott USD 23.66B 146M 2024-12
Bayer EUR 34.44B 1.31B 2024-12
Bio-Rad Laboratories USD 3.03B 25.32M 2024-12
EDAP TMS EUR 63.94M 3.39M 2024-09
J&J USD 55.89B 2.64B 2024-12
Roche Holding CHF 40.04B 6.41B 2024-12
Siemens EUR 68.67B 7.32B 2024-12
Thermo Fisher Scientific USD 22.14B 1.65B 2024-12
Tosoh JPY 759.05B 2.51B 2024-12
Trinity Biotech USD 46.08M 95K 2024-09
Veracyte USD 372.27M 15.41M 2024-12



Trinity Biotech Omløpsmidler - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.